Eurazeo SE

As of June 30, 2026, Eurazeo SE carries a market capitalization of 2.56B, placing it among publicly traded companies globally. Its enterprise value stands at 4.37B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Eurazeo SE's next confirmed earnings release is scheduled for March 11, 2027.

As of June 30, 2026, Eurazeo SE has 63.87M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Eurazeo SE maintains a current ratio of 0.29, meaning it holds 0.3x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 22, 2026, Eurazeo SE's stock has declined approximately 22.32% over the past 52 weeks. The 50-day moving average sits at 47.60, while the 200-day moving average is 46.33.

As of June 30, 2026, Eurazeo SE holds 90.98M in cash and equivalents against 1.65B in total debt, resulting in a net debt position of 1.49B. Total book value stands at 6.01B, with working capital of -872.33M providing operational flexibility.

Eurazeo SE's most recent stock split took place on May 9, 2019 with a 20:21 split ratio.